Evidence map›Paper›PMID 37853808›Full record

ArticleProtein science : a publication of the Protein Society2023

Revisiting the hydrolysis of ampicillin catalyzed by Temoneira-1 β-lactamase, and the effect of Ni(II), Cd(II) and Hg(II).

Zeyad H Nafaee, Viktória Egyed, Attila Jancsó, Annamária Tóth, Adeleh Mokhles Gerami, Thanh Thien Dang, Juliana Heiniger-Schell, Lars Hemmingsen, Éva Hunyadi-Gulyás, Gábor Peintler and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 58% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 6 countries.

Zeyad H NafaeeDepartment of Molecular and Analytical Chemistry, University of Szeged, Szeged, Hungary.
Viktória EgyedDepartment of Molecular and Analytical Chemistry, University of Szeged, Szeged, Hungary.
Attila JancsóDepartment of Molecular and Analytical Chemistry, University of Szeged, Szeged, Hungary.
Annamária TóthDepartment of Molecular and Analytical Chemistry, University of Szeged, Szeged, Hungary.
Adeleh Mokhles GeramiSchool of Particles and Accelerators, Institute for Research in Fundamental Sciences (IPM), Tehran, Iran.
Thanh Thien DangInstitute for Materials Science and Center for Nanointegration Duisburg-Essen (CENIDE), University of Duisburg-Essen, Essen, Germany.
Juliana Heiniger-SchellEuropean Organization for Nuclear Research (CERN), Geneva, Switzerland.
Lars HemmingsenDepartment of Chemistry, University of Copenhagen, Copenhagen, Denmark.
Éva Hunyadi-GulyásLaboratory of Proteomics Research, Biological Research Centre, Hungarian Research Network (HUN-REN), Szeged, Hungary.
Gábor PeintlerDepartment of Physical Chemistry and Material Sciences, University of Szeged, Szeged, Hungary.
Béla GyurcsikDepartment of Molecular and Analytical Chemistry, University of Szeged, Szeged, Hungary.ORCID 0000-0003-1894-7414
University of Szeged · HUUniversity of Duisburg-Essen · DEHUN-REN Szegedi Biológiai Kutatóközpont · HUInstitute for Research in Fundamental Sciences · IRUniversity of Babylon · IQUniversity of Copenhagen · DK

Funding

EURONSEuropean Union's Horizon 2020 Framework 101057511 (EURO-LABS)European Union's Horizon 2020 Framework 654002 (ENSAR2)FCT-Portugal CERN-FIS-PAR-0005-2017Federal Ministry of Education and Research 05K16PGAFederal Ministry of Education and Research 05K22PGAHungarian National Research, Development and Innovation Office 2019-2.1111-TÉT-2019-00089Hungarian National Research, Development and Innovation Office GINOP-2.3.2-15-2016-00001Hungarian National Research, Development and Innovation Office GINOP-2.3.2-15-2016-00020Hungarian National Research, Development and Innovation Office GINOP-2.3.2-15-2016-00038Nemzeti Kutatási Fejlesztési és Innovációs Hivatal GINOP-2.3.2-15-2016-00038NICE
6 · The paper itself

Abstract

β-Lactamases grant resistance to bacteria against β-lactam antibiotics. The active center of TEM-1 β-lactamase accommodates a Ser-Xaa-Xaa-Lys motif. TEM-1 β-lactamase is not a metalloenzyme but it possesses several putative metal ion binding sites. The sites composed of His residue pairs chelate borderline transition metal ions such as Ni(II). In addition, there are many sulfur-containing donor groups that can coordinate soft metal ions such as Hg(II). Cd(II) may bind to both types of the above listed donor groups. No significant change was observed in the circular dichroism spectra of TEM-1 β-lactamase on increasing the metal ion content of the samples, with the exception of Hg(II) inducing a small change in the secondary structure of the protein. A weak nonspecific binding of Hg(II) was proven by mass spectrometry and

Indexed as

CadmiumMercuryAmpicillinbeta-LactamasesCatalysisEscherichia coliHydrolysisIonsKineticsAmpicillinbeta-LactamasesCadmiumIonsMercury199mHg perturbed angular correlation spectroscopy of γ-rayscircular dichroismmass spectrometryreaction kineticsTEM-1 β-lactamasetoxic metal binding

Identifiers

PMID37853808
PMCPMC10661098
OpenAlexW4387765789

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.